Home › Compare › ATGGF vs BTI

ATGGF vs BTI: Dividend Comparison 2026

ATGGF yields 5000.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATGGF wins by $62217131802825.31M in total portfolio value
10 years
ATGGF
ATGGF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full ATGGF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — ATGGF vs BTI

📍 ATGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATGGFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATGGF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ATGGF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATGGF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, ATGGF beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATGGF + BTI for your $10,000?

ATGGF: 50%BTI: 50%
100% BTI50/50100% ATGGF
Portfolio after 10yr
$31108565901412.70M
Annual income
$29,930,990,143,689,105,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

ATGGF
No analyst data
Altman Z
34.8
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATGGF buys
0
BTI buys
0
No recent congressional trades found for ATGGF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATGGFBTI
Forward yield5000.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$62217131802825.35M ✓$37.7K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$2,786.64
Total dividends collected$62057786341622.61M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ATGGF vs BTI ($10,000, DRIP)

YearATGGF PortfolioATGGF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$510,700$500,000.00$11,299$598.92+$499.4K → ATGGF
2$24,410,935$23,864,485.98$12,794$703.91+$24.40M → ATGGF
3$1,092,192,501$1,066,072,800.30$14,518$829.07+$1092.18M → ATGGF
4$45,746,366,951$44,577,720,975.17$16,513$978.64+$45746.35M → ATGGF
5$1,793,932,828,410$1,744,984,215,772.56$18,827$1,157.84+$1793932.81M → ATGGF
6$65,871,973,805,320$63,952,465,678,921.49$21,518$1,373.12+$65871973.78M → ATGGF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$24,657$1,632.46+$2265146887.58M → ATGGF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$28,329$1,945.74+$72954689148.97M → ATGGF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$32,637$2,325.33+$2201076182660.85M → ATGGF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$37,708$2,786.64+$62217131802825.31M → ATGGF

ATGGF vs BTI: Complete Analysis 2026

ATGGF — Stock

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Full ATGGF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this ATGGF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATGGF vs SCHDATGGF vs JEPIATGGF vs OATGGF vs KOATGGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.